Human T cell lymphotropic virus-1 (HTLV-1) primarily infects CD4 + T cells, causing inflammatory disorders or a T cell malignancy in 5% to 10% of carriers. The cytotoxic T lymphocyte (CTL) response is a key factor that controls the viral load and thus the risk of disease. 
immunophenotype is poorly defined. Here, we aimed to identify a cell-surface molecule expressed by both Tax + and Tax 
CADM1
+ cells were lysed at a very low rate by autologous CTLs, however, were efficiently killed when loaded with exogenous peptide antigen. High expression of CADM1 on most HTLV-1-infected cells in the face of enhanced CTL counterselection implies that CADM1 confers a strong benefit on the virus.
Author Summary
Human T cell lymphotropic virus-1 (HTLV-1) infects white blood cells (CD4 + T cells) for the lifetime of the host. The immune response limits viral spread, and people with a weak immune response have a high risk of developing an aggressive blood cancer, or a condition
Introduction
Human T-lymphotropic virus 1 (HTLV-1) is a retrovirus that predominantly infects CD4 + T
cells. An estimated 10-20 million people are infected, with regions of high prevalence including Japan, Africa, the Caribbean and South America. The viral burden (proviral load, PVL) is strongly correlated with the risk of disease [1] . Between 1% and 6% of HTLV-1-infected individuals develop a T cell malignancy known as adult T cell leukemia/lymphoma (ATL), and an additional 2-3% suffer from a variety of inflammatory disorders, the most prevalent of which is HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although HTLV-1 was the first retrovirus observed to be pathogenic in humans, both effective treatment and a vaccine remain elusive. HTLV-1 persists within an infected individual by infectious spread across the virological synapse and by mitotic replication of infected cells [2, 3] ; virus particles are usually undetectable in peripheral blood [4] . The proviral integration site imparts each infected T cell clone with a different pattern and intensity of viral gene expression [5, 6] . Of these, Tax and HTLV-1 basic leucine zipper protein (HBZ), two regulatory proteins, play an important role in viral pathogenesis. The transcriptional transactivator, Tax, encoded in the positive strand in the regulatory (pX) region of the virus, controls the expression of viral proteins (Pol, Gag and Env) as well as many host genes [7] . The negative strand-encoded accessory gene HBZ can inhibit Tax function and modify transcription of various host genes [7] .
The PVL of HTLV-1 reaches a stable ('set-point') level in each individual [8] , which is maintained by the equilibrium between the proliferation of infected cells and their elimination by activated cytotoxic T lymphocytes (CTLs) [9, 10] . Tax, which is immunodominant, is subject to strong selection pressure from the autologous CTL response [11] , and a high lytic efficiency of HTLV-1-specific CTLs (defined as the rate of clearance of Tax + CD4 + T cells/% CD8 + T cells/ day) is associated with low PVL and a low risk of HAM/TSP [12] . Tax expression in fresh peripheral blood mononuclear cells (PBMCs) is typically low in asymptomatic HTLV-1 carriers (ACs) and is silenced in~50% of ATL clones [13] [14] [15] . In addition, CTL-selected Tax sequence variants are generally defective in their transactivating function [11] , impairing expression of positive strand-encoded viral genes. In contrast, HBZ is persistently expressed at low levels under the control of SP1 transcription factors [16] . HBZ minimizes its exposure to the host immune response by virtue of low protein expression, low immunogenicity and poor binding to Class 1 MHC alleles [17, 18] . Compared with Tax-specific CTLs, HBZ-specific CTLs are present at lower frequency in the peripheral blood and kill fewer HTLV-1-infected cells in vitro [17, 18] . However, HBZ-specific CTLs appear to be more effective in controlling HTLV-1 during chronic infection in vivo [18, 19] . A limitation of the previously described assay of anti-HTLV-1 CTL lytic efficiency [12] is that the identification of HTLV-1 + cells was defined by Tax expression, so the lysis rate of Tax − cells-including those that express the key CTL target antigen HBZ-was not quantified. To date, there has been no practicable means to differentiate an HTLV-1-infected cell from an uninfected cell without destroying it in the process, either by permeabilizing it to detect Tax or other viral proteins, or by extracting DNA to detect the viral genome. The aim of the present study was to identify the cell-surface phenotype that most efficiently distinguishes viable HTLV-1-infected cells from uninfected cells, to allow more accurate analysis of the cellular immune response to the virus and the frequency and phenotype of HTLV-1-infected cells. Several activation markers, costimulatory receptors, chemokine and interleukin receptors and adhesion molecules are strongly expressed on HTLV-1-infected cells and serve as possible markers of HTLV-1 infection. These molecules include the IL-2 receptor α chain (CD25) [20] , chemokine receptor 4 (CCR4/CD194) [21, 22] and intercellular adhesion molecule 1 (ICAM-1/CD54) [23, 24] . CD25 is induced by Tax, and the CD4 + CD25
+ population is typically~90% HTLV-1-infected [20, 25] . CCR4 is not directly induced by Tax [21] , but CCR4 + cells appear to be preferentially infected by HTLV-1, perhaps because they are attracted to infected cells as a result of Tax-induced expression of CCL22 [26] . Yamano et al. (2009) recommended the use of both CD25 and CCR4 to isolate HTLV-1-infected cells with high purity [27] . ICAM-1, also induced by Tax, aids in the formation of the virological synapse [28] [29] [30] . However, although CD25, CCR4 and ICAM-1 are highly expressed in HTLV-1 carriers with a high viral load, they are also expressed on activated T cells and regulatory T-cells during inflammatory and immune responses to pathogens. Cell adhesion molecule 1 (CADM1), also known as tumour suppressor in lung cancer 1 (TSLC1), nectin-like protein 2 (Necl-2), immunoglobulin superfamily member 4 (IGSF4), synaptic cell adhesion molecule (SynCAM) or spermatogenic immunoglobulin superfamily (SgIGSF) is a cell-surface molecule that has recently been proposed as a marker of malignant cells in ATL patients [31] [32] [33] . CADM1 is a nectin-like cell adhesion molecule of the immunoglobulin superfamily. It was initially identified as a tumour suppressor of a range of solid cancers (breast, ovarian, cervical and colorectal carcinomas, melanomas and neuroblastomas) [34] . Although CADM1 is expressed in a wide range of tissues, it is usually absent in leukocytes; typically 1% of T cells are CADM1 + [31, 32, [34] [35] [36] . CADM1 can form both homophilic and heterophilic interactions that stabilise cell-to-cell interactions. Outside-in CADM1 signalling can trigger the rearrangement of the actin cytoskeleton to alter cell polarity and motility [37] . CADM1 also interacts with another immunoglobulin superfamily cell-surface protein, Class-1 MHC-restricted T-cell associated molecule (CRTAM/CD355/Cytotoxic and Regulatory T Cell Molecule) on activated NK, CD8 + T and NKT cells. This interaction enhances NK cell-mediated cytotoxicity and IFN-γ secretion by CD8 + T cells [38, 39] . CADM1 is consistently expressed on T-cells in ATL patients and in HTLV-1-transformed cell lines [31, 32] ; the percentage of CD4 + CADM1 + cells in patients with ATL positively correlates with both the PVL and the frequency of morphologically abnormal lymphocytes [32] . Immunohistochemical staining of CADM1 in organs of NOD-SCID/γc null mice transplanted with ATL cells showed a correlation between the level of CADM1 expression on ATL cells and the ability of the ATL cells to invade solid organs such as the liver, ovaries and lungs. It has been postulated that the homophilic adhesion promotes the growth of ATL cells in these organs, in which CADM1 expression is indigenous [31, 40] .
In the present study we evaluated the specificity of CD25, CCR4, ICAM-1 and CADM1 as markers of HTLV-1 infection in uncultured PBMCs of individuals with non-malignant HTLV-1 infection (ACs and patients with HAM). We then used the surface markers with the best combination of sensitivity and specificity to quantify and compare the rate at which autologous CTLs lysed Tax-expressing and non-expressing HTLV-1-infected cells.
Results
The frequency of CADM1 + CD4 + T cells is positively correlated with HTLV-1 proviral load (Fig 2A) . There was no significant change in the frequency of CADM1 + CD4 + T cells during incubation in vitro. identified only a third of the Tax − infected population detected by CADM1 (Fig 2B) , and the low intensity of expression of CD25 made it difficult to distinguish CD25 + cells from CD25 -cells. 
CD4
+ cells (median 22% of total load), which had a low per-cell proviral load (0.05 copies/cell), but were the most abundant population identified in this analysis (Fig 3 and S9B Fig) . Although CADM1 + CD8 + cells are heavily infected, their contribution to the proviral load was highly variable between donors (contributing between 1% and 37% of total proviral load, median contribution 7.7%); however, CADM1 remains a useful marker for enriching infected CD8 + cells. infected cells with high purity even in fresh PBMCs, we conclude that CADM1 is the best single cell-surface marker for HTLV-1 infection identified to date.
HTLV-1 Tax protein enhances CADM1 expression in response to cellular stimulation
In order to further elucidate the role of HTLV-1 in the observed CADM1 expression, we tested whether a range of candidate HTLV-1 gene products could induce CADM1 expression on a CADM1 negative human T cell line. We observed that transfection with Tax or HBZ alone was not sufficient to induce CADM1 expression (Fig 4) . As HBZ mRNA possesses biological activities distinct from HBZ protein, we also utilised a construct which expresses HBZ S1 with a mutation in the initiation codon:HBZ-TTG [42] . This construct did not induce CADM1 expression on unstimulated CEM cells. We hypothesised that HTLV-1 might modify the expression in response to an external stimulus. When stimulated with PMA/CAI, a fraction of CEM cells expressed CADM1. Tax transfection induced a twofold increase in the number of cells expressing CADM1 (Fig 4A) . The intensity of CADM1 expression by Tax-transfected PMA/CAI stimulated cells was also significantly higher than the intensity of GFP transfected cells which were stimulated in the same way (Fig 4B) . HBZ protein, but not HBZ RNA, consistently downregulated PMA/CAI induced CADM1 (3/3 biological replicates), and could reverse Tax-mediated enhancement of CADM1 expression (3/3 biological replicates).
CADM1 expression is associated with efficient CTL-mediated killing of infected cells
Previous work indicates that an efficient Tax-specific CTL response is associated with a lower PVL [12, 43] and a lower risk of HAM. However, most infected cells do not express Tax ex vivo or in short-term culture in vitro. MacNamara et al. (2010) showed that an HBZ-specific CTL response was associated with effective control of HTLV-1 in vivo [18] . We therefore wished to measure the rate at which Tax -CADM1 + cells are killed by CTLs. We used the infected cell elimination assay [12] to quantify the selective pressure exerted by autologous CD8 + T cells on the different cell subpopulations in vitro, using samples from 23 infected individuals (11 ACs and 12 patients with HAM) Fig 5A and 5B. Incorporation of counting beads in the assay enabled us to quantify the cells of each different phenotype and hence calculate the rate at which each population was lysed by CTL ( Fig 5C) . 
CADM1 determines the susceptibility of infected cells to CTL-mediated lysis
To test whether expression of CADM1 is associated with enhanced target cell killing by CTLs specific to an antigen unrelated to HTLV- (Fig 7) . In contrast, the smaller Tax + CADM1 -population escaped lysis and increased + infected individuals (AC, n = 3; HAM, n = 3) were placed in culture to allow viral protein expression. After 6h incubation, cells were loaded with 0-2μM of an HLA-A*02-restricted CMV peptide, pp65 (NLVPMVATV) and co-cultured with a pp65-specific CTL clone at an E:T ratio of 1:1 for a further 12 hours. Cells were then stained for surface and intracellular antigens and analysed by flow cytometry. That is, the use of CADM1 alone identified twice the number of infected cells identified by the combination of CD25 and CCR4. CADM1 also identified a population of CD8 + cells which were heavily infected with the virus. CADM1 has been reported as a surface marker of ATL cells [31] [32] [33] . The results of the present study extend the use of CADM1 as a marker of HTLV-1 infection to those without ATL.
Kobayashi et al. reported that CADM1
+ cells were frequently HTLV-1 infected and that the percentage of CADM1 + cells (both CD7 dim and CD7 -) reflected disease status [45, 46] . These authors also suggested that the appearance of CADM1 + cells is a marker of progression to ATL. However, we detected CADM1 expression in the PBMCs of all ACs and patients with HAM tested. We hypothesise that although ATL cells may arise from CADM1 + cells (expanded clones in ATL patients express CADM1 [31] ), the expression of CADM1 in ACs or patients with HAM does not presage the onset of ATL. Rather, our data indicate that the frequency of CADM1 + cells reflects the PVL; a higher PVL is associated with a higher risk of ATL.
It remains unknown what induces CADM1 expression in HTLV-1-infected cells. There are conflicting reports on whether Tax induces CADM1. While we and others (Nakahata et did not increase with Tax expression; (ii) a significant proportion of CADM1 + cells did not express Tax; (iii) Tax is silenced, mutated or deleted in~65% of ATL cases [13] [14] [15] whereas CADM1 is expressed in virtually all cases [31, 33] . We observed that HBZ protein could downregulate CADM1 expression in response to an external stimulus, even in the presence of Tax. We postulate that the ability of the virus to modulate the level of CADM1 expression is advantageous to viral persistence. Indeed, it has recently been demonstrated that CADM1 plays an important role in the constitutive NF-κB activation observed in HTLV-1-infected cells [47] .
To analyse the CD8 + T-cell response to HTLV-1-infected cells, we used a modified version of the functional assay previously described [12] . The modifications provided two significant advantages over the original assay: (i) the use of counting beads made it possible to enumerate cells in several target populations (defined by different phenotypes), and thus to quantify the rate at which they are killed by CTLs.
(ii) The use of CADM1 made it possible to estimate the rate of lysis of the Tax and CRTAM. Although the CD8 + T cells had a much greater frequency of expression of CADM1 than CRTAM, the frequency of CADM1 expression bore no relationship to the CTL efficiency, and in fact represents the frequency of HTLV-1 infected CD8 + T cells. However, the frequency of CRTAM expression on CD8 + T cells was associated with high rates of CTL lysis.
We propose that the interaction of CADM1 with CRTAM stabilises and prolongs the contact between the infected cell and the CTL and lowers the threshold of CTL activation.
To summarise, efficient CTL-mediated lysis of HTLV-1-infected cells is associated with the expression of CADM1 on the target cell and the high affinity ligand CRTAM on the effector CTL. Since CADM1 expression is tolerated in the face of enhanced CTL surveillance of HTLV-1-infected cells, we infer that CADM1 expression plays an important role in the persistence of HTLV-1.
Materials and Methods

Ethics statement
All donors attended the National Centre for Human Retrovirology (Imperial College Healthcare NHS Trust, St Mary's Hospital, London) and gave written informed consent in accordance with the Declaration of Helsinki, with the approval of UK National Research Ethics Service (15/SC/0089).
Primary cells
Samples were donated by 29 ACs, 1 HTLV-1 + subject with polymyositis (P), 30 patients with HAM/TSP and 8 uninfected individuals (S1 Table) . PBMCs were isolated from whole blood by density-gradient centrifugation using Histopaque-1077 (Sigma) and cryopreserved in FBS (Invitrogen) containing 10% dimethylsulphoxide (Sigma). Genomic DNA was extracted from unfixed PBMCs using the DNeasy kit (Qiagen) according to the manufacturer's protocol. The lysis step was extended from 10 minutes at 56°C to 16 hours at 62°C when extracting DNA from formaldehyde-fixed cells. To quantify the PVL, a series of dilutions of genomic DNA starting from 5ng/μl was subjected to real-time quantitative PCR (qPCR) with the following primers: Tax: SK43 5'-CGGATACCCAGTCTACGTGT-3' and SK44 5'-GAGCCGATAACGC GTCCATCG-3'; GAPDH: GAPDHF 5'-AACAGCGACACCCATCCTC-3' and GAPDHR 5'-CATACCAGGAAATGAGCTTGACAA-3'. qPCR was performed using the QuantStudio 7 Flex real-time PCR system (Life technologies) with the standard Fast SYBRgreen (Life technologies) thermal cycle protocol. A patient-derived infected CD4 + T cell clone with a mapped single integrated provirus was used as a standard reference [41] .
Flow cytometric analysis of marker expression
PBMCs were analysed either uncultured or after culturing for 18 hours at a density of 1 x 10 6 cells/ml in RPMI-1640 (Sigma) containing 10% FBS, 2mM L-glutamine (Sigma), 50 U/ml penicillin, 50μg/ml streptomycin (RPMI10, Sigma), supplemented with 20nM concanamycin A (CMA, Calbiochem). This incubation allowed the onset of spontaneous Tax expression while CD8 + T-cell degranulation was inhibited by concanamycin A. Cells were washed once with PBS (Sigma), then stained with a fixable viability dye (Live/Dead blue or Live/Dead near infrared, Molecular Probes) at 1μl/ml for 5 minutes. All steps were carried out at room temperature unless stated otherwise. Cells were washed with FACS buffer (PBS 7% normal goat serum, Sigma). Then they were stained for 20 minutes with antibodies specific for surface markers, including CD3-Qdot605 (clone UCHT1, Molecular Probes); CD4-eFluor450 (RPA-T4, eBioscience); CD8-AF700 (LT8, AbD Serotec); CCR4-PerCP-Cy5.5 (TG6/CCR4, Biolegend); ICAM-1-PE (HA58, Biolegend); CD25-APC (M-A251, BD) and CADM1 (3E1, MBL) biotinylated using EZ-Link Micro Sulfo-NHS-LC-Biotinylation Kit (Thermo Fisher Scientific). Unbound antibodies were removed by washing with FACS buffer. The cells were then stained for 10 min with Streptavidin-PECy7 (0.4μl/100μl, Biolegend). After another wash with FACS buffer, the cells were fixed with fixation/permeabilisation buffer (FoxP3 buffer set, eBioscience) for 30 minutes. The cells were then washed with the permeabilisation buffer and stained for the intracellular viral protein Tax for 25 minutes using the LT-4 antibody conjugated to AF488 (Y. Tanaka). Finally the cells were washed and resuspended in PBS, after which they were acquired using a BD LSRFortessa. Data was analyzed using Kaluza software (Beckman Coulter). The gating strategy is illustrated in S1 /ml in the presence or absence of 10 ng/ml phorbol 12-myristate 13-acetate (PMA) and 0.5 μg/ml calcimycin (CAI, Sigma). After 16h culture, cells were harvested, stained with a viability stain and biotinylated anti-CADM1, followed by Streptavidin-PEDazzle (Biolegend). Cells were analysed by flow cytometry within 1 h.
Infected cell elimination assay (by autologous CTL)
CD8
+ T cells were depleted from PBMCs by magnetic cell separation (Miltenyi Biotech), then mixed with the CD8-depleted fraction at a range of ratios (including the individual's physiological CD4 + :CD8 + ratio) and co-cultured for 18 hours at a density of 1 x 10 6 cells/ml in RPMI10 supplemented with 20μg/ml DNase (Sigma). All samples were assayed in duplicate. Following co-culture, 10% of the cells in each tube were set aside for estimation of absolute cell counts and the remainder were stained as described above with a viability stain, anti-CD3-BV510 (UCHT-1, Biolegend), -CD4-BV605 (RPA-T4, Biolegend), -CRTAM-PE (Cr24.1, Biolegend), -CD8-AF700, -CADM1-Biotin and -Tax-Cy5. For absolute cell counts, cells were stained with CD4-BV605 and CD8-AF700 for 30 min and, without washing, fixed with 2% paraformaldehyde (Sigma) for 30 minutes. A fixed number of CountBright absolute counting beads (Molecular Probes) were added to each sample before flow cytometric analysis. Thus, the absolute number of CD4 + and CD8 + T cells per tube was calculated and used to calculate the rate of clearance of target CD4 + T cells per percentage CD8 + T cells per day, as described in Asquith et al 2005 [12] .
CMV CTL clone
A cytomegalovirus (CMV)-specific CD8 + T cell clone (a gift from Tao Dong) that recognises an HLA-A Ã 0201-restricted peptide, PP65 (NLVPMVATV), was expanded by coculturing with gamma-irradiated (3000 rads) PBMCs in RPMI10 containing 50 μg/ml phytohemagglutinin (Roche) and 100 IU/ml IL-2 (Promocell). The cells were fed with fresh medium and IL-2 every 3-4 days. The CTLs were used in the susceptibility assay on day 17 post stimulation.
Assay of target cell sensitivity to CTL CD4 + T cells were isolated from HLA-A Ã 0201 + PBMCs using magnetic cell separation (Miltenyi Biotech) and cultured for 6 hours (1 x 10 6 cells/ml in RPMI10 containing 20μg/ml DNase), to allow Tax expression. The cells were then loaded with the CMV peptide pp65 (Think Peptides) at a range of concentrations (0-2 μM). CMV-specific CTLs were added to the peptideloaded CD4 + cells at an effector:target ratio of 1:1 and co-cultured for 12 hours. All samples were assayed in duplicate. A small portion of cells was used to determine absolute cell counts and the remainder were stained with a viability stain, anti-CD3-BV510, -CD4-BV605, -CRTAM-PE, -CD8-AF700, -CADM1-Biotin and -Tax-Cy5.
Supporting Information (TIF)
